Michael D Wendt
Affiliation: Abbott Laboratories
- Wendt M. Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein-protein interaction. Expert Opin Drug Discov. 2008;3:1123-43 pubmed publisher..The example of ABT-263 provides evidence that the larger family of PPI targets is more tractable than may have been thought. ..